类风湿性关节炎：数十年后早期治疗的益处。 - Suppr

Suppr

超能文献

Rheumatoid arthritis: The benefits of early treatment after decades.

作者信息

Zink Angela, Albrecht Katinka

机构信息

German Rheumatism Research Centre (DRFZ), Epidemiology Unit, Charitéplatz 1, 10117 Berlin, Germany.

出版信息

Nat Rev Rheumatol. 2017 Aug;13(8):458-459. doi: 10.1038/nrrheum.2017.104. Epub 2017 Jun 29.

DOI:10.1038/nrrheum.2017.104

PMID:28660916

Abstract

摘要

相似文献

Rheumatoid arthritis: The benefits of early treatment after decades.类风湿性关节炎：数十年后早期治疗的益处。

Nat Rev Rheumatol. 2017 Aug;13(8):458-459. doi: 10.1038/nrrheum.2017.104. Epub 2017 Jun 29.

The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing.类风湿关节炎早期治疗的益处：指征性混杂因素及治疗时机问题。

Arthritis Rheum. 2003 Jan;48(1):1-5. doi: 10.1002/art.10732.

Early Diagnosis and Treatment of Rheumatoid Arthritis.类风湿关节炎的早期诊断与治疗

Prim Care. 2018 Jun;45(2):237-255. doi: 10.1016/j.pop.2018.02.010.

Are biologics more effective than classical disease-modifying antirheumatic drugs?生物制剂比传统抗风湿病情缓解药更有效吗？

Arthritis Res Ther. 2008;10(5):118. doi: 10.1186/ar2491. Epub 2008 Sep 19.

An Early Rheumatoid Arthritis Treatment Evaluation Registry (ERATER) in the United States.美国的一个早期类风湿性关节炎治疗评估登记处（ERATER）。

Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S178-81.

The comparative effects of phenylbutazone and G27202 (metabolite I) in patients with rheumatoid arthritis: an assessment of methods for antirheumatic drug evaluation.保泰松与G27202（代谢物I）对类风湿性关节炎患者的比较疗效：抗风湿药物评估方法的评价

Arthritis Rheum. 1959 Jun;2(3):212-23. doi: 10.1002/1529-0131(195906)2:3<212::aid-art1780020304>3.0.co;2-q.

[Glucocorticoids in rheumatoid arthritis: almost always or hardly ever?].[糖皮质激素在类风湿性关节炎中的应用：几乎总是使用还是几乎从不使用？]

Reumatol Clin. 2011 Nov-Dec;7(6):407-11. doi: 10.1016/j.reuma.2011.01.008. Epub 2011 May 18.

Initial management of rheumatoid arthritis.类风湿关节炎的初始治疗。

Rheum Dis Clin North Am. 2012 May;38(2):311-25. doi: 10.1016/j.rdc.2012.05.003.

Preliminary report of the antirheumatic action of heparin and paritol-C in gout and rheumatoid arthritis.肝素和帕立骨化醇 -C在痛风和类风湿性关节炎中抗风湿作用的初步报告

Am J Med Sci. 1952 Mar;223(3):258-61. doi: 10.1097/00000441-195203000-00004.

Potential for altering rheumatoid arthritis outcome.改变类风湿性关节炎预后的可能性。

Rheum Dis Clin North Am. 2005 Nov;31(4):763-72. doi: 10.1016/j.rdc.2005.07.008.

引用本文的文献

Vascular synovial phenotype indicates poor response to JAK inhibitors in rheumatoid arthritis patients: a pilot study.血管滑膜表型提示类风湿关节炎患者对JAK抑制剂反应不佳：一项初步研究。

PeerJ. 2024 Nov 29;12:e18631. doi: 10.7717/peerj.18631. eCollection 2024.

Clinical Applications of Synovial Biopsy.滑膜活检的临床应用

Front Med (Lausanne). 2019 May 10;6:102. doi: 10.3389/fmed.2019.00102. eCollection 2019.

Real benefits of ultrasound evaluation of hand and foot synovitis for better characterisation of the disease activity in rheumatoid arthritis.超声评估手足滑膜炎对类风湿关节炎疾病活动更好的特征化的实际获益。

Eur Radiol. 2019 Nov;29(11):6345-6354. doi: 10.1007/s00330-019-06187-8. Epub 2019 Apr 26.

Clin Rheumatol. 2019 Sep;38(9):2433-2441. doi: 10.1007/s10067-019-04555-9. Epub 2019 Apr 19.

Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?靶向滑膜微环境的早期变化：一类新型免疫调节治疗方法？

Ann Rheum Dis. 2019 Feb;78(2):186-191. doi: 10.1136/annrheumdis-2018-214294. Epub 2018 Dec 14.

Liquid biopsies to guide therapeutic decisions in rheumatoid arthritis.液体活检指导类风湿关节炎的治疗决策。

Transl Res. 2018 Nov;201:1-12. doi: 10.1016/j.trsl.2018.07.004. Epub 2018 Jul 19.

本文引用的文献

Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register.类风湿关节炎起始队列患者的 20 年结局和早期治疗与死亡率及残疾的相关性：来自诺福克关节炎登记处的结果。

Arthritis Rheumatol. 2017 Aug;69(8):1566-1575. doi: 10.1002/art.40090. Epub 2017 Jul 10.

Brief Report: Rheumatoid Arthritis as the Underlying Cause of Death in Thirty-One Countries, 1987-2011: Trend Analysis of World Health Organization Mortality Database.简要报告：1987-2011 年三十一个国家类风湿关节炎导致的死亡原因：世界卫生组织死亡率数据库的趋势分析。

Arthritis Rheumatol. 2017 Aug;69(8):1560-1565. doi: 10.1002/art.40091. Epub 2017 Jul 10.

Patients with Early Rheumatoid Arthritis in the 2000s Have Equal Disability and Pain Despite Less Disease Activity Compared with the 1990s: Data from the BARFOT Study over 8 Years.与20世纪90年代相比，21世纪患有早期类风湿性关节炎的患者尽管疾病活动度较低，但残疾和疼痛程度相同：来自BARFOT研究8年的数据。

J Rheumatol. 2017 Jun;44(6):723-731. doi: 10.3899/jrheum.161235. Epub 2017 Apr 1.

Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?近年来新发类风湿关节炎（RA）患者心血管死亡率降低：RA心血管疾病新时代的曙光？

J Rheumatol. 2017 Jun;44(6):732-739. doi: 10.3899/jrheum.161154. Epub 2017 Apr 1.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.EULAR 推荐的类风湿关节炎治疗策略：2016 年更新版

Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6.

Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis.早期关节炎患者的非药物和药物干预：一项系统文献综述，为2016年欧洲抗风湿病联盟（EULAR）早期关节炎管理建议更新提供依据

RMD Open. 2017 Jan 5;3(1):e000404. doi: 10.1136/rmdopen-2016-000404. eCollection 2017.

Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies.二十年来类风湿关节炎管理中不断变化的临床模式：系列观察性研究

BMC Musculoskelet Disord. 2016 Jan 27;17:44. doi: 10.1186/s12891-016-0897-y.

Treating rheumatoid arthritis to target: recommendations of an international task force.靶向治疗类风湿关节炎：国际工作组的建议。

Ann Rheum Dis. 2010 Apr;69(4):631-7. doi: 10.1136/ard.2009.123919. Epub 2010 Mar 9.

Early rheumatoid arthritis -- is there a window of opportunity?早期类风湿性关节炎——是否存在治疗的窗口期？

J Rheumatol Suppl. 2007 Nov;80:1-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验